Literature DB >> 14664751

Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes.

Keith I Block1, Charlotte Gyllenhaal.   

Abstract

Interactions between herbal medicines and conventional drugs have recently been reported; the most significant herb with such drug interactions is Saint John's wort, an inducer of cytochrome P450 3A3/4, an enzyme responsible for clearance of many clinically important drugs from the body. Foods (especially grapefruit) and habits or lifestyle factors such as smoking or alcohol consumption may also alter the metabolism of drugs through effects on the cytochrome P450 system. The authors review here the functioning of the drug-metabolizing enzymes and discuss their particular significance in cancer chemotherapy treatment. They then present the herbal medicines, foods, and lifestyle factors that induce or inhibit drug-metabolizing enzymes that are important for both cancer chemotherapy drugs and drugs used adjunctively in cancer treatment. It is notable that no actual herb-drug interactions have been reported clinically in cancer treatment, and their potential for interaction still must be regarded as theoretical. Although some chemotherapy patients may be interested in taking herbal medicines that could potentially interact with cancer chemotherapy agents, it may be wise to counsel them to use other means of addressing the problems for which they use specific herbs during the time they receive chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14664751     DOI: 10.1177/153473540200100118

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  9 in total

Review 1.  Drug interactions between herbal and prescription medicines.

Authors:  Elizabeth M Williamson
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Prevalence of traditional, complementary, and alternative medicine use by cancer patients in low income and lower-middle income countries.

Authors:  Jacob Hill; Coleman Mills; Quefeng Li; Jennifer S Smith
Journal:  Glob Public Health       Date:  2018-10-16

3.  Prevalence of traditional, complementary, and alternative medicine (TCAM) among adult cancer patients in Malawi.

Authors:  Jacob Hill; Ryan Seguin; Agness Manda; Maria Chikasema; Olivia Vaz; Quefeng Li; Hannan Yang; Satish Gopal; Jennifer S Smith
Journal:  Cancer Causes Control       Date:  2022-04-13       Impact factor: 2.532

4.  Patient-sharing relationship between Chinese medicine doctors and other physicians: costs and outcomes of breast cancer survivorship care.

Authors:  Chiu-Mei Yeh; Yiing-Jenq Chou; Shun-Ku Lin; Chia-Jen Liu; Nicole Huang
Journal:  J Cancer Surviv       Date:  2021-02-18       Impact factor: 4.442

5.  Optimizing chemotherapy: concomitant medication lists.

Authors:  M H Hanigan; B L Dela Cruz; S S Shord; P J Medina; J Fazili; D M Thompson
Journal:  Clin Pharmacol Ther       Date:  2010-12-01       Impact factor: 6.875

6.  Facilitators and barriers to traditional medicine use among cancer patients in Malawi.

Authors:  Jacob Hill; Ryan Seguin; Twambilile Phanga; Agness Manda; Maria Chikasema; Satish Gopal; Jennifer S Smith
Journal:  PLoS One       Date:  2019-10-21       Impact factor: 3.240

7.  "Part of the Conversation": A Qualitative Study of Oncology Healthcare Professionals' Experiences of Integrating Standardized Assessment and Documentation of Complementary Medicine.

Authors:  Lynda G Balneaves; Cody Z Watling
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.279

8.  Chimonanthus nitens var. salicifolius Aqueous Extract Protects against 5-Fluorouracil Induced Gastrointestinal Mucositis in a Mouse Model.

Authors:  Zhenze Liu; Jun Xi; Sven Schröder; Weigang Wang; Tianpei Xie; Zhugang Wang; Shisan Bao; Jian Fei
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-03       Impact factor: 2.629

Review 9.  Valerian: no evidence for clinically relevant interactions.

Authors:  Olaf Kelber; Karen Nieber; Karin Kraft
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-30       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.